Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
Mesa Laboratories (NASDAQ:MLAB) announced it will release financial results for the second quarter of fiscal 2026 after market close on Thursday, November 6, 2025.
The company is a global designer and manufacturer of life science tools and quality control solutions for pharmaceutical, healthcare and medical device industries. Media and investors may contact Gary Owens, President and CEO, or John Sakys, CFO at +1-303-987-8000. More information is available at www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) ha annunciato che divulgherà i risultati finanziari per il secondo trimestre dell'anno fiscale 2026 dopo la chiusura del mercato giovedì 6 novembre 2025.
L'azienda è un designer e produttore globale di strumenti di life science e soluzioni di controllo qualità per i settori farmaceutico, sanitario e dei dispositivi medici. I media e gli investitori possono contattare Gary Owens, Presidente e CEO, o John Sakys, CFO al +1-303-987-8000. Ulteriori informazioni sono disponibili su www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) anunció que publicará los resultados financieros del segundo trimestre del año fiscal 2026 tras el cierre del mercado el jueves 6 de noviembre de 2025.
La empresa es un diseñador y fabricante global de herramientas de ciencias de la vida y soluciones de control de calidad para las industrias farmacéutica, de atención sanitaria y de dispositivos médicos. Los medios y los inversores pueden contactar a Gary Owens, Presidente y CEO, o a John Sakys, CFO al +1-303-987-8000. Más información disponible en www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) 은 회계연도 2026년의 두 번째 분기 재무 실적을 2025년 11월 6일 목요일 장 마감 후 발표할 예정입니다.
회사는 제약, 헬스케어 및 의료기기 산업을 위한 생명과학 도구 및 품질 관리 솔루션의 글로벌 디자이너이자 제조업체입니다. 언론 매체와 투자자들은 Gary Owens, 회장 겸 CEO, 또는 John Sakys, CFO에게 연락할 수 있습니다. 전화번호: +1-303-987-8000. 더 자세한 정보는 www.mesalabs.com에서 확인할 수 있습니다.
Mesa Laboratories (NASDAQ:MLAB) a annoncé qu'elle Publiera les résultats financiers du second trimestre de l'exercice 2026 après la clôture du marché le jeudi 6 novembre 2025.
L'entreprise est un concepteur et fabricant mondial d'outils de sciences de la vie et de solutions de contrôle qualité pour les industries pharmaceutique, de la santé et des dispositifs médicaux. Les médias et les investisseurs peuvent contacter Gary Owens, Président et CEO, ou John Sakys, CFO au +1-303-987-8000. Plus d'informations sur www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) gab bekannt, dass die finanziellen Ergebnisse für das zweite Quartal des Geschäftsjahres 2026 nach Börsenschluss am Donnerstag, dem 6. November 2025 veröffentlicht werden.
Das Unternehmen ist ein weltweiter Designer und Hersteller von Life-Science-Werkzeugen und Qualitätskontrolllösungen für die Pharma-, Gesundheits- und Medizingeräteindustrie. Medien und Investoren können sich an Gary Owens, Präsident und CEO, oder John Sakys, CFO unter der Telefonnummer +1-303-987-8000 wenden. Weitere Informationen finden Sie unter www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) أعلنت أنها ستصدر النتائج المالية لـ الربع الثاني من السنة المالية 2026 بعد إغلاق السوق يوم الخميس 6 نوفمبر 2025.
الشركة هي مصممة ومصنعة عالمياً لأدوات علوم الحياة وحلول مراقبة الجودة لصناعات الأدوية والرعاية الصحية والأجهزة الطبية. يمكن لوسائل الإعلام والمستثمرين التواصل مع Gary Owens، الرئيس التنفيذي، أو John Sakys، المدير المالي على الرقم +1-303-987-8000. يمكن العثور على المزيد من المعلومات على www.mesalabs.com.
Mesa Laboratories (NASDAQ:MLAB) 宣布将于2026财年第二季度在市场收盘后公布财务业绩，时间为2025年11月6日，星期四。
该公司是一家全球性的生命科学工具和质量控制解决方案设计与制造商，服务于制药、医疗保健和医疗器械行业。媒体和投资者可联系 Gary Owens，总裁兼首席执行官，或 John Sakys，首席财务官，电话为+1-303-987-8000。更多信息请访问www.mesalabs.com。
- None.
- None.
LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
For more information about the Mesa, please visit our website at www.mesalabs.com.
FAQ
When will Mesa Laboratories (MLAB) report Q2 fiscal 2026 results?
How can investors access Mesa Laboratories (MLAB) November 6, 2025 earnings release?
Who are the Mesa Laboratories (MLAB) investor contacts for the November 6, 2025 release?
Will Mesa Laboratories (MLAB) provide a conference call or webcast for the November 6, 2025 results?
What period does Mesa's Q2 fiscal 2026 earnings release on November 6, 2025 cover?
Where can I find historical results and filings for Mesa Laboratories (MLAB)?
